eDOTS: Improving the Treatment of Pulmonary Tuberculosis in Xinjiang, China

References

• Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8(1):19. doi:10.1016/S2213-2600(19)30418-7
   PubMed Web of Science ®Google Scholar
• National Technical Steering Group of the Epidemiological Sampling Survey for TB. Implementing office of the epidemiological sampling survey for TB. The prevalence of pulmonary tuberculosis in a national survey across China in 2010. Chin J Antituberculosis. 2012;35(9):665–668.
   Google Scholar
• Onozaki I, Law I, Sismanidis C, et al. National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned. Trop Med Int Health. 2015;20(9):1128–1145. doi:10.1111/tmi.12534
   PubMed Web of Science ®Google Scholar
• Zumla A, George A, Sharma V, et al. The WHO 2014 global tuberculosis report--further to go. Lancet Glob Health. 2015;3(1):e10–2. doi:10.1016/S2214-109X(14)70361-4
   PubMed Web of Science ®Google Scholar
• Yang JM, Jieensi S, Tai XR, et al. Analysis of tuberculosis epidemiological survey conducted in 2010-2011 in Xinjiang Uygur Autonomous Region. Chin J Antituberculosis. 2013;35(12):960–964.
   Google Scholar
• Huang R, Li XY, Xiao H, et al. Application of spatial statistical analysis in tuberculosis study. Chin J Antituberculosis. 2016;38(6):432–435. doi:10.3969/j.issn.1000-6621.2016.06.003
   Google Scholar
• Li YH, Wu G, Qi L. Analysis of monthly report of tuberculosis control in Xinjiang in 2005. Endemic Dis Bull. 2006;21(6):29–32. doi:10.13215/j.cnki.jbyfkztb.2006.06.015
   Google Scholar
• Zhao Z, Liu NQ, Aihaiti Y, et al. Epidemiological and spatial distribution characteristics of tuberculosis in Xinjiang Uygur Autonomous Region from 2008 to 2018. Chin J Antituberculosis. 2019;41(8):893–899. doi:10.26914/c.cnkihy.2019.061369
   Google Scholar
• Technical Guidance Group of the Fifth National TB Epidemiological Survey. The office of the fifth national TB epidemiological survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberculosis. 2012;34(8):485–508.
   Google Scholar
• World Health Organization. Country profiles for 30 high TB burden countries. Global tuberculosis report; 2019. Available from: https://www.who.int/tb/publications/global_report/tb19_Report_country_profiles_15October2019.pdf?ua=1. Accessed December 4, 2023.
   Google Scholar
• Frieden TR, Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clin Chest Med. 2005;26(2):197–205. doi:10.1016/j.ccm.2005.02.001
   PubMed Web of Science ®Google Scholar
• Wang LX, Zhang H, Ruan YZ, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
   PubMed Web of Science ®Google Scholar
• Gu XM, Wu WD. Effective evaluation of national tuberculosis control programme in Xinjiang. Bull Dis Control. 2005;20(4):53–54,59.
   Google Scholar
• Angella M, Wilson T, Aaron TM, et al. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: mixed methods study. J Clin Tuberc Other Mycobact Dis. 2019;17:100119. doi:10.1016/j.jctube.2019.100119
   PubMedGoogle Scholar
• Subbaraman R, Mondesert LD, Musiimenta A, et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health. 2018;3:e00101. doi:10.1136/bmjgh-2018-001018
   Web of Science ®Google Scholar
• Nouvet E, Knoblauch AM, Passe I, et al. Perceptions of drones, digital adherence monitoring technologies and educational videos for tuberculosis control in remote Madagascar: a mixed-method study protocol. BMJ Open. 2019;9:e028073. doi:10.1136/bmjopen-2018-028073
   PubMed Web of Science ®Google Scholar
• Ngwatu BK, Nsengiyumva NP, Oxlade O, et al. Collaborative group on the impact of digital technologies on TB. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J. 2018;51(1):1701596. doi:10.1183/13993003.01596-2017
   PubMed Web of Science ®Google Scholar
• Maraba N, Orrell C, Chetty-Makkan CM, et al. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial. Trials. 2021;22(1):389. doi:10.1186/s13063-021-05337-y
   PubMed Web of Science ®Google Scholar
• Leddy A, Ggita J, Berger CA, et al. Barriers and facilitators to implementing a digital adherence technology for tuberculosis treatment supervision in Uganda: qualitative study. J Med Internet Res. 2023;25(25):e38828. doi:10.2196/38828
   PubMedGoogle Scholar
• Manyazewal T, Woldeamanuel Y, Holland DP, et al. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial. Trials. 2020;21(1):383. doi:10.1186/s13063-020-04324-z
   PubMed Web of Science ®Google Scholar
• Thomas BE, Kumar JV, Onongaya C, et al. Explaining differences in the acceptability of 99DOTS, a cell phone-based strategy for monitoring adherence to tuberculosis medications: qualitative study of patients and health care providers. JMIR Mhealth Uhealth. 2020;8(7):e16634. doi:10.2196/16634
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission of the People’s Republic of China. Diagnosis for Pulmonary Tuberculosis (WS288-2017). Beijing: China Standard Press; 2018:1–24.
   Google Scholar
• World Health Organization. Treatment of tuberculosis: guidelines. WHO guidelines approved by the guidelines review committee. Geneva; 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK138748/pdf/Bookshelf_NBK138748.pdf. Accessed December 4, 2023.
   Google Scholar
• Marion SB, Francis MP, Kennedy MN, et al. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial. Trials. 2019;20(1):426. doi:10.1186/s13063-019-3483-3484
   PubMedGoogle Scholar
• Liu X, Terrence B, Bruce T, et al. Usability of a medication event reminder monitor system (merm) by providers and patients to improve adherence in the management of tuberculosis. Int J Env Res Pub He. 2017;14(10):1115. doi:10.3390/ijerph14101115
   PubMed Web of Science ®Google Scholar
• Ananya P, Upasna A, Jaya PT, et al. ”99dots” techno-supervision for tuberculosis treatment – a boon or a bane? Exploring challenges in its implementation at a tertiary centre in Delhi, India. Indian J Tuberc. 2020;67(1):46–53. doi:10.1016/j.ijtb.2019.08.010
   PubMedGoogle Scholar
• Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99dots information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India. 2019;36(2):108–111. doi:10.4103/lungindia.lungindia_86_18
   PubMed Web of Science ®Google Scholar
• Nezenega ZS, Perimal-Lewis L, Maeder AJ. Factors influencing patient adherence to tuberculosis treatment in Ethiopia: a literature review. Int J Environ Res Public Health. 2020;17(15):5626. doi:10.3390/ijerph17155626
   PubMed Web of Science ®Google Scholar
• Xu WG, Lu W, Zhou Y, et al. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9(1). doi:10.1186/1472-6963-9-169
   Google Scholar
• Rocha M, Pereira S, Ferreira L, et al. The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J. 2003;21(5):785–788. doi:10.1183/09031936.03.00077302
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao MG, Wang YX, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15(1):474. doi:10.1186/s12889-015-1789-z
   PubMed Web of Science ®Google Scholar
• Yao S, Huang W, Susan VDH, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011;11:11. doi:10.1186/1472-6963-11-341
   PubMed Web of Science ®Google Scholar
• Gong XJ, Li YH, Wang J, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in Xinjiang, China: a prospective study. RSC Adv. 2018;8(16):8983–8989. doi:10.1039/C7RA11820A
   PubMed Web of Science ®Google Scholar
• Chen W, Li Y, Yang H, et al. Is tuberculosis health education reaching the public in China? A cross-sectional survey in Guizhou Province. BMJ Open. 2016;6(9):e013534. doi:10.1136/bmjopen-2016-013534
   PubMed Web of Science ®Google Scholar
• Wang ZY, Zhang LJ, Liu YH, et al. The effectiveness of E-learning in continuing medical education for tuberculosis health workers: a quasi-experiment from China. Infect Dis Poverty. 2021;10(1):72. doi:10.1186/s40249-021-00855-y
   PubMed Web of Science ®Google Scholar
• Bermingham WH, Bhogal R, Arudi Nagarajan S, et al. Practical management of suspected hypersensitivity reactions to anti-tuberculosis drugs. Clin Exp Allergy. 2022;52(3):375–386. doi:10.1111/cea.14084
   PubMed Web of Science ®Google Scholar
• Prasad R, Singh A, Gupta N. Adverse drug reactions in tuberculosis and management. Indian J Tuberc. 2019;66(4):520–532. doi:10.1016/j.ijtb.2019.11.005
   PubMedGoogle Scholar